$MSP Recovery (LIFW.US)$Ticker change to MSPR Monday to consolidate services. Even with negative profit margin, of note, company had $10M settlements from property and casualty insurers and acquired Medicare claims valued $10.6B. Low float. Currently trading above 10/20 EMA suggesting short term bullishness. SI 162%, 0 shares LTB $Roth CH Acquisition V Co(Delisted) (ROCL.US)$Ticker change tomorr...
51
25
6
Report
105642463xu
:
It's a good idea not to hold it overnight, otherwise you‘ll be doomed if you fall asleep like me.
$Athira (ATHA.US)$ This is their balance sheet as of SEP 2024, in this it shows stock holders equity 57Mil, which is now down to 25M(Market cap), so the liability is 25+28=53Mil which is still less than the cash they hold 69Mil...
$Athira (ATHA.US)$ Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association's 35th International Symposium on ALS/MND Friday, 6th December at 5:30 pm BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today presented preclinical data highli...
1
2
Report
152466230
:
where did your first hear their news drop?
$Athira (ATHA.US)$no downside they closed down that failing company months ago false news been working out of their new lab for almost a year now and with AI about to cut workforce cost we will see more profits 📈 😉
Athira Stock Forum
$Roth CH Acquisition V Co(Delisted) (ROCL.US)$ Ticker change tomorr...
This is their balance sheet as of SEP 2024, in this it shows stock holders equity 57Mil, which is now down to 25M(Market cap), so the liability is 25+28=53Mil which is still less than the cash they hold 69Mil...
someone new something 👀
Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association's 35th International Symposium on ALS/MND
Friday, 6th December at 5:30 pm
BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today presented preclinical data highli...
No comment yet